>>15616539
Q 1220
CHAI Foundation
Chai Foundation
for Medical Research & Life Extension, Inc.
A 501 (C) (3) Non-Profit Corporation
CHAI Foundation for Medical Research & Life Extension, Inc. (CHAI Foundation), a twenty-four year old 501(c)(3) non-profit organization in Phoenix, AZ,has identified an anti-neoplastic material that destroys cancerous cells without the toxicity of current modalities. With future work it could be a preventative.
We seek collaboration with another research group due to the loss of Dr. Eric Reeder Brown, our world-class Research Director and Microbiologist (M.D., Ph.D. Virology & Immunology) to an unfortunate accident. Dr. Brown earlier identified a promising immunotherapeutic cancer research treatment breakthrough designated “Protein B” which appears to affect several cancer sites (not the Protein B on the internet). We have ascertained that this anti-cancer material is non-toxic to animals and man; that it shows varying degrees of effectiveness on several cancer sites, i.e., amelioration, regression, and/or complete disappearance of tumor; that pain relief has been noted; and it appears to cross the blood-brain barrier.
The mechanism for Protein B is that it enhances the immune system by particularly enhancing Beta cells causing them in turn to strengthen specific anti-cancer antibodies which attack and destroy malignant cells without harming normal cells. The active material is a biological agent which results from a pre-treated serum injected into a particular large animal strain (which is not sacrificed).
The serum causes the animal’s system to create an immune-stimulating antibody. Dr. Brown stated it gave the animal itself life-time immunity from neoplastic disease. According to Dr. Brown, “Not only is Protein B a hormone, but it destroys the cell membrane and the cytoplasm of the cell. This sheds a whole new explanation on how cancer cells are destroyed in the body.” He added, “The material could become a preventative with future work.“ Dr. Brown furthermore held a theory as from which organ in the body the hormone or autocoid originates.
A Preliminary Patent Application (PPA) has been filed. Funding for collaboration is needed to make additional anti-cancer serum for new tests for comparison to earlier studies. With proper collaboration, and funding for same, we estimate it could take approximately nine to twelve months to reproduce a new batch of the anti-neoplastic material and run comparative animal tests to earlier studies – hoping to lead to an early IND application for human studies in the U.S. for comparison to those done outside the U.S. by Dr. Brown – with very exciting and promising results of 60% to 85% without toxicity on several malignant sites.
Dr. Brown’s research may well prove cancer to be one disease – or a variation thereof – as opposed to the accepted idea that it is scores of diseases.
Dr. Brown theorized that “cancer was caused by a virus or a virus particle.” And that the material that genes are composed of are the same as that of viruses.”
Earlier research showed that this virus modified a particular chromosome – which he identified – that he said grows smaller rather than larger – which is how, for instance, an individual gets leukemia.
The active material is a biological agent resulting from a pre-treated serum found to enhance the immune system by particularly enhancing Beta cells, causing them to strengthen specific anti-cancer antibodies. (Because of Protein B’s affect on Beta cells, we are considering the possibility of the drug also having an effect in Diabetes – but separate research in this area would have to be undertaken to properly verify).
We have ascertained that this anti-cancer material appears to cross the blood-brain barrier.
Additional confidential information can be shared via an NDA with interested collaborators at an accredited research center.
https://chaifoundation.org